Patents by Inventor Istvan Boldogh

Istvan Boldogh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEIL2 PROTEIN THERAPY FOR TREATMENT OF VIRAL INFECTION
    Publication number: 20230355725
    Abstract: Certain embodiments are directed to methods for treating a virus induced dysregulated inflammatory response in a subject in need of such treatment. The methods can include the administration a NEIL2 peptide or a composition comprising the NEIL2 peptide to the subject.
    Type: Application
    Filed: January 9, 2023
    Publication date: November 9, 2023
    Inventors: Tapas Hazra, Istvan Boldogh, Chien-Te K. Tseng
  • METHODS FOR TREATING ALLERGIC AIRWAY INFLAMMATION
    Publication number: 20160311911
    Abstract: Provided herein are methods for treating a symptom and/or clinical sign associated with an allergy that includes neutrophil recruitment, such as allergic airway inflammation. In one embodiment, the method includes administering to a subject a composition that includes a CXCR2 inhibitor, a MD2 inhibitor, a MyD88 inhibitor, or a combination thereof. The subject can have an allergy that includes neutrophil recruitment such as allergic airway inflammation, or be at risk of an allergy that includes neutrophil recruitment such as an allergic airway inflammation.
    Type: Application
    Filed: April 22, 2016
    Publication date: October 27, 2016
    Inventors: Sanjiv Sur, Istvan Boldogh
  • THERAPEUTIC USES OF COLOSTRININ
    Publication number: 20110098216
    Abstract: There is provided the use of Colostrinin for the treatment of obesity.
    Type: Application
    Filed: October 21, 2010
    Publication date: April 28, 2011
    Applicant: REGEN THERAPEUTICS PLC
    Inventors: Istvan Boldogh, Marian L. Kruzel
  • Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules
    Publication number: 20070065399
    Abstract: The present invention provides methods that utilize compositions containing colostrinin, a constituent peptide thereof, an active analog thereof, and combinations thereof, as modulators of intracellular signaling molecules, for example.
    Type: Application
    Filed: August 25, 2006
    Publication date: March 22, 2007
    Applicant: Board of Regents, The University of Texas System
    Inventors: Istvan Boldogh, G. Stanton, Jerzy Georgiades, Thomas Hughes, Marian Kruzel
  • Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules
    Patent number: 7119064
    Abstract: The present invention provides methods that utilize compositions containing colostrinin, a constituent peptide thereof, an active analog thereof, and combinations thereof, as modulators of intracellular signaling molecules, for example.
    Type: Grant
    Filed: October 22, 2003
    Date of Patent: October 10, 2006
    Assignee: Board of Regents, The University of Texas System
    Inventors: Istvan Boldogh, G. John Stanton, Jerzy A. Georgiades, Thomas K. Hughes, Jr., Marian Kruzel
  • Methods for inhibiting allergic inflammation and other responses initiated by pollens, molds, and other non-animal derived allergens
    Publication number: 20060198904
    Abstract: Disclosed are methods for treating or preventing allergic inflammation in a subject and methods for treating or preventing one or more symptoms of allergic inflammation in a subject. The methods include administering to the subject a compound which inhibits reactive oxygen species. Also disclosed are methods for reducing a non-animal-derived allergen's ability to initiate an allergenic process and for reducing prooxidant activity of a non-animal-derived allergen. The methods include contacting the non-animal-derived allergen with an agent which inhibits reactive oxygen species. Methods for screening a compound for its usefulness as an agent for reducing a non-animal-derived allergen's ability to initiate an allergenic process and/or for its usefulness as a therapeutic agent for treating or preventing allergic inflammation and/or the symptoms associated therewith are also disclosed.
    Type: Application
    Filed: November 20, 2003
    Publication date: September 7, 2006
    Inventors: Istvan Boldogh, Sanjiv Sur
  • Use of colostrinin, constituent peptides thereof, and analogs thereof, as oxidative stress regulators
    Patent number: 6939847
    Abstract: The present invention provides methods that utilize compositions containing colostrinin, an constituent peptide thereof, an active analog thereof, and combinations thereof, as an oxidative stress regulator.
    Type: Grant
    Filed: October 28, 2002
    Date of Patent: September 6, 2005
    Assignee: Board of Regents, The University of Texas System
    Inventors: G. John Stanton, Thomas K. Hughes, Jr., Istvan Boldogh
  • Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines
    Patent number: 6903068
    Abstract: The present invention discloses a use of colostrinin, a constituent peptide thereof, and/or an analog thereof as an immunological regulator and as a blood cell regulator in animals including humans.
    Type: Grant
    Filed: August 17, 2000
    Date of Patent: June 7, 2005
    Assignee: Board of Regents, The University of Texas System
    Inventors: G. John Stanton, Thomas K. Hughes, Jr., Istvan Boldogh, Jerzy A. Georgiades
  • Use of colostrinin, constituent peptides thereof, and analogs thereof as inhibitors of apoptosis and other cellular damage
    Publication number: 20050042300
    Abstract: The present invention provides methods that utilize compositions containing colostrinin, a constituent peptide thereof, an active analog thereof, and combinations thereof, as inhibitors of apoptosis, for example.
    Type: Application
    Filed: October 22, 2003
    Publication date: February 24, 2005
    Inventors: Istvan Boldogh, G. Stanton, Jerzy Georgiades, Thomas Hughes, Marian Kruzel
  • Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neuronal cell differentiation
    Patent number: 6852685
    Abstract: The present invention discloses a use of colostrinin, a constituent peptide thereof, and/or an analog thereof as a neural cell regulator in animals including humans.
    Type: Grant
    Filed: August 17, 2000
    Date of Patent: February 8, 2005
    Assignee: Board of Regents, The University of Texas System
    Inventors: Istvan Boldogh, G. John Stanton, Thomas K. Hughes, Jr.
  • Use of colostrinin,constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules
    Publication number: 20040266681
    Abstract: The present invention provides methods that utilize compositions containing colostrinin, a constituent peptide thereof, an active analog thereof, and combinations thereof, as modulators of intracellular signaling molecules, for example.
    Type: Application
    Filed: October 22, 2003
    Publication date: December 30, 2004
    Inventors: Istvan Boldogh, G. John Stanton, Jerzy A. Georgiades, Thomas K. Hughes, Marian Kruzel
  • Use of colostrinin, constituent peptides thereof, and analogs thereof, as oxidative stress regulators
    Publication number: 20030091606
    Abstract: The present invention provides methods that utilize compositions containing colostrinin, an constituent peptide thereof, an active analog thereof, and combinations thereof, as an oxidative stress regulator.
    Type: Application
    Filed: October 28, 2002
    Publication date: May 15, 2003
    Applicant: Board of Regents, The University of Texas System
    Inventors: G. John Stanton, Thomas K. Hughes, Istvan Boldogh
  • Use of colostrinin, constituent peptides thereof, and analogs thereof, as oxidative stress regulators
    Patent number: 6500798
    Abstract: The present invention provides methods that utilize compositions containing colostrinin, an constituent peptide thereof, an active analog thereof, and combinations thereof, as an oxidative stress regulator.
    Type: Grant
    Filed: August 17, 2000
    Date of Patent: December 31, 2002
    Assignee: Board of Regents, The University of Texas System
    Inventors: G. John Stanton, Thomas K. Hughes, Jr., Istvan Boldogh